Informe de análisis del tamaño, la participación y las tendencias del mercado global de pruebas de función pulmonar: panorama general del sector y pronóstico hasta 2032

Solicitud de índiceSolicitud de índice Hable con el analistaHable con el analista Informe de muestra gratuitoInforme de muestra gratuito Consultar antes de comprarConsultar antes Comprar ahoraComprar ahora

Informe de análisis del tamaño, la participación y las tendencias del mercado global de pruebas de función pulmonar: panorama general del sector y pronóstico hasta 2032

  • Medical Devices
  • Published Report
  • Sep 2024
  • Global
  • 350 Páginas
  • Número de tablas: 984
  • Número de figuras: 37

Global Pulmonary Function Testing Market

Tamaño del mercado en miles de millones de dólares

Tasa de crecimiento anual compuesta (CAGR) :  % Diagram

Chart Image USD 3.88 Billion USD 6.23 Billion 2024 2032
Diagram Período de pronóstico
2025 –2032
Diagram Tamaño del mercado (año base)
USD 3.88 Billion
Diagram Tamaño del mercado (año de pronóstico)
USD 6.23 Billion
Diagram Tasa de crecimiento anual compuesta (CAGR)
%
Diagram Jugadoras de los principales mercados
  • BD
  • SCHILLER CoSMED srl
  • NSPIRE Healthcare
  • MGC DIAGNOSTICS CORPORATION
  • ndd Medical Technologies

Segmentación del mercado global de pruebas de función pulmonar por tipo (hardware, servicios y software), tipo de paciente (pediátrico, adulto y geriátrico), aplicación (enfermedad pulmonar obstructiva y restrictiva), usuario final (hospital, clínicas especializadas, laboratorios de diagnóstico, centros de atención domiciliaria, etc.): tendencias y pronóstico del sector hasta 2032.

Mercado de pruebas de función pulmonar

Tamaño del mercado de pruebas de función pulmonar

  • El tamaño del mercado global de pruebas de función pulmonar se valoró en USD 3.88 mil millones en 2024  y se espera que alcance  los USD 6.23 mil millones para 2032 , con una CAGR del 6,10% durante el período de pronóstico.
  • El crecimiento del mercado está impulsado en gran medida por la creciente adopción y el progreso tecnológico en el diagnóstico respiratorio y la monitorización de pacientes, lo que conduce a una mayor digitalización tanto en entornos clínicos como domiciliarios.
  • Además, la creciente demanda de soluciones precisas, no invasivas e integradas para evaluar la función pulmonar está consolidando las pruebas de función pulmonar (PFP) como una herramienta moderna de diagnóstico y monitorización de primera elección. Estos factores convergentes están acelerando la adopción de soluciones de pruebas de función pulmonar, impulsando así significativamente el crecimiento del sector.

Análisis del mercado de pruebas de función pulmonar

  • Los dispositivos de prueba de la función pulmonar (PFT), que ofrecen una medición precisa del volumen pulmonar, la capacidad, los caudales y el intercambio de gases, son componentes cada vez más vitales de los sistemas modernos de diagnóstico respiratorio y de monitorización de pacientes tanto en entornos clínicos como domésticos debido a su mayor precisión, no invasividad y conocimientos completos sobre la salud pulmonar.
  • La creciente demanda de dispositivos PFT se ve impulsada principalmente por la adopción generalizada de tecnologías de diagnóstico avanzadas, la creciente prevalencia de enfermedades respiratorias entre los consumidores y una creciente preferencia por la detección temprana y el tratamiento de las enfermedades pulmonares.
  • América del Norte domina el mercado de pruebas de función pulmonar con una participación de mercado del 38,9%, caracterizada por una alta prevalencia de enfermedades respiratorias, una sólida infraestructura de atención médica y una fuerte presencia de actores clave de la industria.
  • Se espera que Asia-Pacífico sea la región de más rápido crecimiento en el mercado de pruebas de función pulmonar durante el período de pronóstico, con una CAGR proyectada del 7,7 %, debido a la creciente urbanización, el aumento de los ingresos disponibles y la mejora de la infraestructura de atención médica.
  • El segmento de aplicaciones para enfermedades pulmonares obstructivas dominó el mercado de sistemas de pruebas de función pulmonar en 2024 con una participación de mercado del 39,8%, impulsado por la alta prevalencia mundial de enfermedad pulmonar obstructiva crónica (EPOC) y asma y la necesidad de monitoreo y manejo continuos de estas condiciones crónicas.

Alcance del informe y segmentación del mercado de pruebas de función pulmonar

Atributos

Perspectivas clave del mercado de las pruebas de función pulmonar

Segmentos cubiertos

  • Por tipo: Hardware, servicios y software
  • Por tipo de paciente: pediátrico, adulto y geriátrico
  • Por aplicación: Enfermedad pulmonar obstructiva y enfermedad pulmonar restrictiva
  • Por usuario final: hospitales, clínicas especializadas, laboratorios de diagnóstico, entornos de atención domiciliaria y otros

Países cubiertos

América del norte

  • A NOSOTROS
  • Canadá
  • México

Europa

  • Alemania
  • Francia
  • Reino Unido
  • Países Bajos
  • Suiza
  • Bélgica
  • Rusia
  • Italia
  • España
  • Pavo
  • Resto de Europa

Asia-Pacífico

  • Porcelana
  • Japón
  • India
  • Corea del Sur
  • Singapur
  • Malasia
  • Australia
  • Tailandia
  • Indonesia
  • Filipinas
  • Resto de Asia-Pacífico

Oriente Medio y África

  • Arabia Saudita
  • Emiratos Árabes Unidos
  • Sudáfrica
  • Egipto
  • Israel
  • Resto de Oriente Medio y África

Sudamerica

  • Brasil
  • Argentina
  • Resto de Sudamérica

Actores clave del mercado

  • ZOLL Medical Corporation (EE. UU.)
  • Teleflex Incorporated (EE. UU.)
  • CAIRE, Inc. (EE. UU.)
  • COSMED srl (Italia)
  • Schiller AG (Suiza)
  • GANSHORN Medizin Electronic GmbH (Alemania)
  • Dispositivos médicos avanzados PulmOne (Israel)
  • ndd Medical Technologies (Suiza)
  • KoKo PFT (Reino Unido)
  • Geratherm Medical AG (Alemania)
  • ECO MEDICS AG (Suiza)
  • Morgan Scientific (EE. UU.)
  • SIBEL, SAU (España)
  • Clarity Medical (India)
  • Data Sciences International (EE. UU.)
  • IngMar Medical (EE. UU.)
  • Sistema Médico JK (India)
  • MEC COMPANY LTD (REINO UNIDO)
  • Medline Industries, LP (EE. UU.)
  • Registradores y sistemas de Medicare (India)
  • VITALOGRAPH (Irlanda)
  • Medical Equipment Europe GmbH (Alemania)
  • CHEST MI, Inc. (Japón)
  • CONTEC MEDICAL SYSTEMS CO., LTD (China)
  • FUKUDA DENSHI (Japón)

Oportunidades de mercado

  • Creciente demanda de dispositivos PFT portátiles y domésticos
  • Integración de IA y salud digital

Conjuntos de información de datos de valor añadido

Además de los conocimientos sobre escenarios de mercado, como valor de mercado, tasa de crecimiento, segmentación, cobertura geográfica y actores principales, los informes de mercado seleccionados por Data Bridge Market Research también incluyen análisis en profundidad de expertos, análisis de precios, análisis de participación de marca, encuesta de consumidores, análisis demográfico, análisis de la cadena de suministro, análisis de la cadena de valor, descripción general de materias primas/consumibles, criterios de selección de proveedores, análisis PESTLE, análisis de Porter y marco regulatorio.

Tendencias del mercado de pruebas de función pulmonar

Creciente adopción de dispositivos PFT portátiles y domésticos

  • Una tendencia significativa y en auge en el mercado global de pruebas de función pulmonar es la creciente adopción de dispositivos de PFT portátiles y domiciliarios, impulsada por la creciente demanda de atención respiratoria descentralizada y centrada en el paciente. Este cambio permite un acceso más amplio a las pruebas, especialmente en regiones remotas o desatendidas, y se alinea con el énfasis global en la telesalud y el manejo de enfermedades crónicas.
    • Por ejemplo, las empresas están desarrollando espirómetros compactos y dispositivos portátiles de PFT que se conectan a teléfonos inteligentes o tabletas, lo que permite a los pacientes realizar pruebas de función pulmonar precisas desde casa. Dispositivos como el MIR Spirobank Smart y el espirómetro doméstico NuvoAir han demostrado una alta usabilidad y una precisión comparable a la de los equipos de laboratorio, lo que los hace viables para el monitoreo rutinario de afecciones como la EPOC y el asma.
  • Estas innovaciones son especialmente valiosas para el manejo de enfermedades respiratorias crónicas, ya que permiten el seguimiento continuo de la función pulmonar sin necesidad de visitas frecuentes al hospital. Los profesionales sanitarios pueden acceder remotamente a los datos de los pacientes a través de plataformas en la nube, identificar signos tempranos de deterioro y ajustar los planes de tratamiento en tiempo real, lo que mejora la adherencia al tratamiento y los resultados.
  • La integración de Bluetooth y la conectividad en la nube en los sistemas portátiles de PFT también mejora el intercambio de datos, la interoperabilidad con los historiales clínicos electrónicos (HCE) y facilita el análisis basado en IA para una toma de decisiones más informada. Esto contribuye a un enfoque más dinámico y basado en datos para la atención respiratoria, tanto en centros de atención primaria como especializada.
  • A medida que los sistemas de salud avanzan hacia modelos de atención preventiva y basada en el valor, la demanda de soluciones de pruebas pulmonares portátiles y fáciles de usar se acelera. Los fabricantes están respondiendo con el lanzamiento de dispositivos móviles y ecosistemas de software que facilitan el diagnóstico remoto y las rutas de atención respiratoria personalizadas.

Dinámica del mercado de pruebas de función pulmonar

Conductor

Necesidad creciente debido a la creciente prevalencia de enfermedades respiratorias y los avances tecnológicos.

  • La creciente prevalencia de enfermedades respiratorias como la enfermedad pulmonar obstructiva crónica (EPOC), el asma y el cáncer de pulmón, junto con los continuos avances tecnológicos en dispositivos de diagnóstico, es un impulsor importante de la mayor demanda de soluciones de pruebas de función pulmonar (PFT).
    • Por ejemplo, en abril de 2024, la adquisición por parte de Clario de ArtiQ, empresa de interpretación de pruebas de función pulmonar (PFT) basada en IA, refuerza su cartera de soluciones respiratorias al integrar capacidades avanzadas de IA. Se espera que estos avances estratégicos de empresas clave impulsen el crecimiento de la industria de las pruebas de función pulmonar durante el período de pronóstico.
  • A medida que los proveedores de atención médica y los pacientes se vuelven más conscientes de la importancia del diagnóstico temprano y el manejo eficaz de las enfermedades pulmonares, los dispositivos PFT ofrecen funciones avanzadas para la medición precisa de los volúmenes, las capacidades y el flujo de aire pulmonares, lo que proporciona información crucial para el diagnóstico y el tratamiento.
  • Además, la creciente popularidad de los dispositivos PFT portátiles y fáciles de usar, junto con el deseo de capacidades de monitoreo remoto, está haciendo de la PFT un componente integral de la atención respiratoria moderna, ofreciendo una integración perfecta con plataformas de salud digitales y registros médicos electrónicos.
  • La comodidad de una evaluación precisa y no invasiva de la función pulmonar en diversos entornos, como hospitales, clínicas y atención domiciliaria, es un factor clave que impulsa la adopción de las PFT. La tendencia hacia la medicina personalizada y la creciente disponibilidad de opciones avanzadas de PFT contribuyen aún más al crecimiento del mercado.

Restricción/Desafío

Preocupación por los altos costos iniciales y la falta de profesionales capacitados

  • Las preocupaciones en torno al alto costo inicial de los sistemas avanzados de pruebas de función pulmonar y la escasez de profesionales capacitados para realizar e interpretar estas pruebas plantean un desafío importante para una penetración más amplia en el mercado.
    • Por ejemplo, los espirómetros digitales avanzados y los sistemas de pletismografía pueden costar entre 2000 y 50 000 USD , lo que los hace inaccesibles para clínicas y profesionales sanitarios más pequeños, especialmente en regiones de bajos ingresos y en desarrollo. Además, aproximadamente el 35 % de los centros sanitarios en las economías en desarrollo se enfrentan a una escasez de neumólogos capacitados, lo que limita la adopción generalizada de los sistemas de PFT.
  • Abordar estos desafíos de costos y experiencia mediante el desarrollo de dispositivos de PFT más asequibles y fáciles de usar, junto con iniciativas de capacitación para profesionales de la salud, es crucial para una adopción más amplia. Si bien los dispositivos básicos de PFT son cada vez más asequibles, las funciones premium, como la IA integrada o el análisis avanzado del intercambio de gases, suelen tener un precio más elevado.
  • Si bien los precios están disminuyendo gradualmente, la prima percibida por la tecnología PFT avanzada aún puede obstaculizar su adopción generalizada, especialmente para aquellos que no ven una necesidad inmediata de las funciones integrales que se ofrecen.
  • Superar estos desafíos mediante una mayor asequibilidad, la educación del consumidor sobre los beneficios del diagnóstico temprano y el desarrollo de opciones de PFT más accesibles será vital para el crecimiento sostenido del mercado.

Alcance del mercado de pruebas de función pulmonar

El mercado global de pruebas de función pulmonar está segmentado según tipo, tipo de paciente, aplicación y usuario final.

  • Por tipo

Según el tipo, el mercado de pruebas de función pulmonar se segmenta en hardware, servicios y software. El segmento de hardware tuvo la mayor participación de mercado en 2024, impulsado por la necesidad esencial de dispositivos físicos como espirómetros y pletismógrafos para realizar pruebas de función pulmonar (PFP). La continua innovación en hardware compacto y portátil también contribuye a su dominio del mercado.

Se anticipa que el segmento de software registrará la CAGR más alta, impulsada por la creciente integración de IA, análisis de datos y soluciones basadas en la nube que mejoran la funcionalidad, la interpretación y la gestión de los datos de PFT.

  • Por tipo de paciente

Según el tipo de paciente, el mercado de pruebas de función pulmonar se segmenta en pediátrico, adulto y geriátrico. El segmento adulto obtuvo la mayor cuota de mercado, dado que la prevalencia de muchas enfermedades respiratorias crónicas aumenta significativamente con la edad, lo que conlleva un mayor volumen de pruebas de función pulmonar realizadas en adultos.

Se prevé que el segmento geriátrico experimente una tasa de crecimiento anual compuesta (TCAC) significativa debido al envejecimiento de la población mundial y a la mayor susceptibilidad de los adultos mayores a diversas afecciones respiratorias, lo que impulsa la demanda de evaluaciones periódicas de la función pulmonar. Por ejemplo, en el mercado más amplio de pruebas de atención domiciliaria.

  • Por aplicación

Según su aplicación, el mercado de pruebas de función pulmonar se segmenta en enfermedad pulmonar obstructiva y enfermedad pulmonar restrictiva. El segmento de la enfermedad pulmonar obstructiva, impulsado principalmente por afecciones como la enfermedad pulmonar obstructiva crónica (EPOC) y el asma, dominó el mercado con una cuota de mercado estimada del 39,8 % en 2024. Este predominio se debe a la alta prevalencia mundial de estas enfermedades crónicas y al papel crucial de las pruebas de función pulmonar en su diagnóstico, evaluación de la gravedad y tratamiento continuo.

Se espera que el segmento de enfermedades pulmonares obstructivas experimente la tasa de crecimiento más rápida entre 2025 y 2032. Este crecimiento está impulsado principalmente por la creciente prevalencia de la enfermedad pulmonar obstructiva crónica (EPOC), el asma y otras afecciones obstructivas, junto con los avances en las tecnologías de diagnóstico.

  • Por el usuario final

En función del usuario final, el mercado de pruebas de función pulmonar se segmenta en hospitales, clínicas especializadas, laboratorios de diagnóstico, centros de atención domiciliaria, entre otros. El segmento hospitalario representó la mayor participación en los ingresos del mercado, con un 50,7 % en 2024, gracias a sus capacidades de diagnóstico integrales, el alto volumen de pacientes y la disponibilidad de equipos avanzados de PFT. Los hospitales actúan como centros de referencia primarios para casos respiratorios complejos.

Se espera que el segmento de entornos de atención domiciliaria sea testigo de la tasa de crecimiento más rápida, impulsada por la creciente preferencia por el monitoreo remoto de pacientes, la conveniencia para el manejo de enfermedades crónicas y la creciente disponibilidad de dispositivos PFT portátiles adecuados para uso en el hogar.

Análisis regional del mercado de pruebas de función pulmonar

  • América del Norte domina el mercado de pruebas de función pulmonar con la mayor participación de mercado, con una participación de mercado del 38,9 % en 2024, impulsada por una alta prevalencia de enfermedades respiratorias, una sólida infraestructura de atención médica y la adopción temprana de tecnologías médicas avanzadas.
  • Los consumidores y proveedores de atención médica de la región valoran mucho la precisión, las capacidades de diagnóstico integral y la integración perfecta que ofrecen los sistemas PFT modernos con otras soluciones de salud digital.
  • Esta adopción generalizada se ve respaldada además por un alto gasto en atención médica, una comunidad médica tecnológicamente avanzada y una creciente conciencia sobre el diagnóstico temprano y la atención médica preventiva, lo que establece la PFT como una solución favorita en hospitales, clínicas e incluso entornos de atención domiciliaria.

Análisis del mercado de pruebas de función pulmonar en EE. UU.

El mercado estadounidense de pruebas de función pulmonar captó la mayor participación en los ingresos, con un 76,3 %, en 2024. Este crecimiento se ve impulsado por la creciente prevalencia de enfermedades respiratorias, la creciente adopción de tecnologías de diagnóstico avanzadas y la expansión de la infraestructura sanitaria. Los consumidores y los profesionales sanitarios priorizan cada vez más la mejora de la monitorización de la salud respiratoria mediante sistemas de prueba inteligentes, precisos y accesibles. La creciente preferencia por las pruebas de función pulmonar (PFT) domiciliarias, sumada a la sólida demanda de monitorización remota e integración digital, impulsa aún más la industria de las pruebas de función pulmonar. Además, la creciente integración de tecnologías de salud digital, como la interpretación basada en IA y la gestión de datos en la nube, contribuye significativamente a la expansión del mercado.

Análisis del mercado europeo de pruebas de función pulmonar

Se proyecta que el mercado europeo de pruebas de función pulmonar se expandirá a una tasa de crecimiento anual compuesta (TCAC) sustancial durante el período de pronóstico de 2025 a 2032, impulsado principalmente por la creciente prevalencia de enfermedades respiratorias, los avances tecnológicos y la creciente demanda de medicina personalizada. El envejecimiento de la población y la concienciación sobre la salud pulmonar están impulsando la adopción de las PFT. Los consumidores y los sistemas sanitarios europeos también se ven atraídos por la precisión y la información completa que ofrecen estos dispositivos. La región está experimentando un crecimiento significativo en aplicaciones hospitalarias, clínicas especializadas y de atención domiciliaria, con la incorporación de las PFT tanto en protocolos de diagnóstico consolidados como en iniciativas emergentes de telesalud.

Análisis del mercado de pruebas de función pulmonar en el Reino Unido

Se prevé que el mercado británico de pruebas de función pulmonar crezca a una tasa de crecimiento anual compuesta (TCAC) notable durante el período de pronóstico, impulsado por la creciente prevalencia de enfermedades respiratorias y la búsqueda de una mayor precisión y comodidad en el diagnóstico. Además, la preocupación por las enfermedades pulmonares crónicas y la salud pública anima tanto a las personas como a los profesionales sanitarios a optar por soluciones integrales de evaluación de la función pulmonar. Se espera que la adopción de dispositivos médicos avanzados en el Reino Unido, junto con su sólida infraestructura sanitaria, siga impulsando el crecimiento del mercado.

Análisis del mercado de pruebas de función pulmonar en Alemania

Se prevé que el mercado alemán de pruebas de función pulmonar (PFP) se expanda a una tasa de crecimiento anual compuesta (TCAC) considerable durante el período de pronóstico, impulsado por una mayor concienciación sobre la salud respiratoria y la demanda de soluciones tecnológicamente avanzadas y precisas. La sólida infraestructura alemana, junto con su énfasis en la innovación y los altos estándares de atención médica, promueve la adopción de las PFP, especialmente en hospitales y laboratorios de diagnóstico. La integración de las PFP con los sistemas de salud digitales también es cada vez más frecuente, con una fuerte preferencia por soluciones de diagnóstico seguras, fiables y de alta calidad que se ajusten a las expectativas de los consumidores y los profesionales clínicos locales.

Análisis del mercado de pruebas de función pulmonar en Asia-Pacífico

Se prevé que el mercado de pruebas de función pulmonar en Asia-Pacífico crezca a la tasa de crecimiento anual compuesta (TCAC) más rápida, del 7,7 %, entre 2025 y 2032 , impulsado por la creciente urbanización, el aumento de la renta disponible y los avances tecnológicos en países como China, Japón e India. La creciente inclinación de la región hacia una mejor infraestructura sanitaria, respaldada por iniciativas gubernamentales que promueven la salud pública, está impulsando la adopción de las pruebas de función pulmonar (PFP). Además, a medida que Asia-Pacífico se consolida como un centro de fabricación de componentes y sistemas de PFP, la asequibilidad y la accesibilidad de las soluciones de PFP se están extendiendo a un público más amplio.

Análisis del mercado de pruebas de función pulmonar en Japón

El mercado japonés de pruebas de función pulmonar está cobrando impulso gracias a la cultura tecnológica del país, la rápida urbanización y la demanda de atención médica avanzada. El mercado japonés prioriza el diagnóstico temprano y la monitorización precisa de las afecciones respiratorias, y la adopción de las pruebas de función pulmonar (PFP) se ve impulsada por el creciente número de pacientes con enfermedades pulmonares crónicas y su integración con los historiales clínicos digitales. El Ministerio de Salud, Trabajo y Bienestar Social informó que la adopción de espirómetros digitales en los hospitales japoneses aumentó del 45 % en 2021 al 72 % en 2023, con proyecciones que alcanzarán el 85 % para 2024. Además, es probable que el envejecimiento de la población japonesa impulse la demanda de soluciones de diagnóstico precisas y fáciles de usar, tanto en el ámbito clínico como en el doméstico.

Análisis del mercado de pruebas de función pulmonar en India

Se prevé que el mercado indio de pruebas de función pulmonar registre su mayor tasa de crecimiento anual compuesto, del 7,8 %, entre 2025 y 2032 , impulsado por la creciente prevalencia de enfermedades respiratorias, el aumento de los niveles de contaminación atmosférica y una mayor concienciación sobre la salud respiratoria. La creciente infraestructura sanitaria del país, sumada a las iniciativas gubernamentales para combatir las enfermedades respiratorias, está impulsando una mayor adopción de soluciones de PFT. El mercado también se beneficia de la creciente demanda de herramientas de diagnóstico portátiles y rentables, lo que facilita el acceso de las PFT a una mayor población.

Cuota de mercado de las pruebas de función pulmonar

La industria de pruebas de función pulmonar está liderada principalmente por empresas bien establecidas, entre las que se incluyen:

  • ZOLL Medical Corporation (EE. UU.)
  • Teleflex Incorporated (EE. UU.)
  • CAIRE, Inc. (EE. UU.)
  • COSMED srl (Italia)
  • Schiller AG (Suiza)
  • GANSHORN Medizin Electronic GmbH (Alemania)
  • Dispositivos médicos avanzados PulmOne (Israel)
  • ndd Medical Technologies (Suiza)
  • KoKo PFT (Reino Unido)
  • Geratherm Medical AG (Alemania)
  • ECO MEDICS AG (Suiza)
  • Morgan Scientific (EE. UU.)
  • SIBEL, SAU (España)
  • Clarity Medical (India)
  • Data Sciences International (EE. UU.)
  • IngMar Medical (EE. UU.)
  • Sistema Médico JK (India)
  • MEC COMPANY LTD (REINO UNIDO)
  • Medline Industries, LP (EE. UU.)
  • Registradores y sistemas de Medicare (India)
  • VITALOGRAPH (Irlanda)
  • Medical Equipment Europe GmbH (Alemania)
  • CHEST MI, Inc. (Japón)
  • CONTEC MEDICAL SYSTEMS CO., LTD (China)
  • FUKUDA DENSHI (Japón)

Últimos avances en el mercado mundial de pruebas de función pulmonar

  • En abril de 2024, Clario, proveedor líder de soluciones para ensayos clínicos, anunció la adquisición de ArtiQ, empresa de interpretación de PFT basada en IA. Esta estrategia busca ampliar la cartera de soluciones respiratorias de Clario mediante la integración de capacidades avanzadas de IA, lo que subraya la creciente tendencia de aprovechar la inteligencia artificial para un análisis de PFT más preciso y eficiente. Este avance pone de manifiesto el compromiso de la industria con la mejora de las capacidades diagnósticas en el ámbito de la atención respiratoria.
  • En septiembre de 2023, PulmOne, desarrollador de dispositivos portátiles para pruebas de función pulmonar, lanzó el MiniBox+ en China. El dispositivo se presentó a neumólogos en el Congreso Anual de 2023 de la Sociedad Torácica China (CTS) a través de su distribuidor HTDK. Esta introducción demuestra la creciente atención a las soluciones de PFT portátiles y accesibles, especialmente en mercados en rápido crecimiento como China, para satisfacer la creciente demanda de una monitorización práctica de la función pulmonar.
  • En mayo de 2023, Vitalograph, líder destacado en diagnóstico respiratorio, amplió su cartera de productos con la presentación del oscilómetro Vitalograph tremoflo C-100 en la Conferencia Internacional de la ATS. Este nuevo dispositivo destaca la transición hacia métodos de prueba avanzados y no invasivos, como la oscilometría, que proporciona información específica sobre la función de las vías respiratorias pequeñas sin necesidad de maniobras forzadas, lo que lo hace ideal para una gama más amplia de pacientes, incluidos los niños. 
  • En abril de 2023, IngMar Medical, empresa especializada en tecnología de simulación respiratoria, presentó la versión 4.3 del software RespiSim. Este avance clave incluye mejoras en la importación y exportación de escenarios, reducción del retardo de simulación y mayor estabilidad de la plataforma. Estas actualizaciones mejoran significativamente la usabilidad y el rendimiento, convirtiéndolo en una herramienta esencial para la formación en terapia respiratoria, contribuyendo a una mejor comprensión y aplicación de los principios de la PFT. 
  • En enero de 2023, CAIRE Inc. adquirió MGC Diagnostics Holdings, Inc., una operación estratégica destinada a aprovechar la extensa red de distribución global y la presencia de fabricación de MGC. Esta adquisición mejora el acceso de los pacientes a los sistemas avanzados de diagnóstico cardiorrespiratorio de MGC, incluidos los equipos de PFT, y refleja la consolidación continua y las alianzas estratégicas en el mercado para ampliar el alcance y la oferta de productos.

SKU-

Obtenga acceso en línea al informe sobre la primera nube de inteligencia de mercado del mundo

  • Panel de análisis de datos interactivo
  • Panel de análisis de empresas para oportunidades con alto potencial de crecimiento
  • Acceso de analista de investigación para personalización y consultas
  • Análisis de la competencia con panel interactivo
  • Últimas noticias, actualizaciones y análisis de tendencias
  • Aproveche el poder del análisis de referencia para un seguimiento integral de la competencia
Solicitud de demostración

Tabla de contenido

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF THE GLOBAL PULMONARY FUNCTION TESTING MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATIONS

1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 DBMR TRIPOD DATA VALIDATION MODEL

2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.6 MULTIVARIATE MODELLING

2.7 MARKET APPLICATION COVERAGE GRID

2.8 PRODUCT LIFELINE CURVE

2.9 DBMR MARKET POSITION GRID

2.1 VENDOR SHARE ANALYSIS

2.11 SECONDARY SOURCES

2.12 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PORTER’S FIVE FORCES

4.2 PESTEL ANALYSIS

5 REGULATORY FRAMEWORK

6 MARKET OVERVIEW

6.1 DRIVERS

6.1.1 INCREASING PREVALENCE OF RESPIRATORY DISEASES

6.1.2 EARLY DETECTION OF RESPIRATORY DISEASES

6.1.3 GROWING GERIATRIC POPULATION

6.1.4 INCREASING PRODUCT LAUNCHES AND EMERGENCE OF HOME TESTING DEVICES

6.2 RESTRAINTS

6.2.1 HIGH COST OF TESTING EQUIPMENT

6.2.2 TECHNOLOGICAL LIMITATION OF TESTING DEVICES

6.3 OPPORTUNITIES

6.3.1 RAPID TECHNOLOGICAL ADVANCEMENTS

6.3.2 RISING STRATEGIC INITIATIVES

6.3.3 GOVERNMENT INITIATIVES AND REIMBURSEMENT POLICIES

6.3.4 PRODUCT DEVELOPMENT FOR AT-HOME TESTING

6.4 CHALLENGES

6.4.1 LACK OF STANDARDIZATION AND VARIABILITY IN TEST RESULTS

6.4.2 LACK OF SKILLED PROFESSIONALS

7 GLOBAL PULMONARY FUNCTION TESTING MARKET, BY TYPE

7.1 OVERVIEW

7.2 HARDWARE

7.2.1 PFT DEVICES

7.2.2 PFT ACCESSORIES & CONSUMABLES

7.2.2.1 SPIROMETRY

7.2.2.2 LUNG VOLUME IN UNIT/ PLETHYSMOGRAPHY TEST

7.2.2.3 GAS EXCHANGE TESTING

7.2.2.4 CARDIOPULMONARY EXERCISE TEST (CPET)

7.2.2.5 PULSE OXIMETRY TEST

7.2.2.6 DIFFUSION CAPACITY TEST

7.2.2.7 MAXIMAL VOLUNTARY VENTILATION

7.2.2.8 OXYGEN TITRATION TEST

7.2.2.9 RESPIRATORY MUSCLE FUNCTION

7.2.2.10 BRONCHIAL PROVOCATION TEST

7.2.2.11 HIGH ALTITUDE SIMULATION TESTING

7.2.3 OTHERS

7.2.3.1 3.2. DIRECT TENDER

7.2.3.2 3.2. RETAIL SALES

7.2.4 OTHERS

7.3 SOFTWARE

7.4 SERVICES

8 GLOBAL PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE

8.1 OVERVIEW

8.2 ADULT

8.2.1 MALE

8.2.2 FEMALE

8.3 GERIATRIC

8.3.1 MALE

8.3.2 FEMALE

8.4 PEDIATRIC

8.4.1 MALE

8.4.2 FEMALE

9 GLOBAL PULMONARY FUNCTION TESTING MARKET, BY APPLICATION

9.1 OVERVIEW

9.2 OBSTRUCTIVE LUNG DISEASE

9.2.1 ASTHMA

9.2.2 CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)

9.2.3 BRONCHIECTASIS

9.2.4 CYSTIC FIBROSIS

9.3 RESTRICTIVE LUNG DISEASE

9.3.1 LUNG CANCER

9.3.2 INTERSTITIAL LUNG DISEASE

9.3.3 AMYOTROPHIC LATERAL SCLEROSIS (ALS)

9.3.4 SCOLIOSIS

9.3.5 SARCOIDOSIS

9.3.6 MUSCULAR DYSTROPHY

10 GLOBAL PULMONARY FUNCTION TESTING MARKET, BY END USER

10.1 OVERVIEW

10.2 HOSPITALS

10.2.1 PUBLIC

10.2.2 PRIVATE

10.3 SPECIALTY CLINICS

10.4 DIAGNOSTICS LABORATORIES

10.5 HOME CARE SETTINGS

10.6 OTHERS

11 GLOBAL PULMONARY FUNCTION TESTING MARKET, BY REGION

11.1 OVERVIEW

11.2 NORTH AMERICA

11.2.1 U.S.

11.2.2 CANADA

11.2.3 MEXICO

11.3 EUROPE

11.3.1 GERMANY

11.3.2 U.K.

11.3.3 FRANCE

11.3.4 FRANCE

11.3.5 ITALY

11.3.6 TURKEY

11.3.7 RUSSIA

11.3.8 SWITZERLAND

11.3.9 NETHERLANDS

11.3.10 SWEDEN

11.3.11 BELGIUM

11.3.12 DENMARK

11.3.13 NORWAY

11.3.14 FINLAND

11.3.15 POLAND

11.3.16 REST OF EUROPE

11.4 ASIA-PACIFIC

11.4.1 JAPAN

11.4.2 CHINA

11.4.3 SOUTH KOREA

11.4.4 INDIA

11.4.5 AUSTRALIA

11.4.6 SINGAPORE

11.4.7 TAIWAN

11.4.8 THAILAND

11.4.9 MALAYSIA

11.4.10 NEW ZEALAND

11.4.11 INDONESIA

11.4.12 VIETNAM

11.4.13 PHILIPPINES

11.4.14 REST OF ASIA-PACIFIC

11.5 MIDDLE EAST AND AFRICA

11.5.1 SOUTH AFRICA

11.5.2 SAUDI ARABIA

11.5.3 U.A.E.

11.5.4 ISRAEL

11.5.5 QATAR

11.5.6 KUWAIT

11.5.7 EGYPT

11.5.8 OMAN

11.5.9 BAHRAIN

11.5.10 REST OF MIDDLE EAST AND AFRICA

11.6 SOUTH AMERICA

11.6.1 BRAZIL

11.6.2 ARGENTINA

11.6.3 REST OF SOUTH AMERICA

12 GLOBAL PULMONARY FUNCTION TESTING MARKET: COMPANY LANDSCAPE

12.1 COMPANY SHARE ANALYSIS: GLOBAL

12.2 COMPANY SHARE ANALYSIS: NORTH AMERICA

12.3 COMPANY SHARE ANALYSIS: EUROPE

12.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC

13 SWOT ANALYSIS

14 COMPANY PROFILES

14.1 VYAIRE MEDICAL, INC.

14.1.1 COMPANY SNAPSHOT

14.1.2 COMPANY SHARE ANALYSIS

14.1.3 PRODUCT PORTFOLIO

14.1.4 RECENT DEVELOPMENTS

14.2 TELEFLEX INCORPORATED

14.2.1 COMPANY SNAPSHOT

14.2.2 REVENUE ANALYSIS

14.2.3 COMPANY SHARE ANALYSIS

14.2.4 PRODUCT PORTFOLIO 488

14.2.5 RECENT DEVELOPMENT 488

14.3 CAIRE INC.

14.3.1 COMPANY SNAPSHOT

14.3.2 COMPANY SHARE ANALYSIS

14.3.3 PRODUCT PORTFOLIO

14.3.4 RECENT DEVELOPMENTS

14.4 COSMED SRL

14.4.1 COMPANY SNAPSHOT

14.4.2 COMPANY SHARE ANALYSIS

14.4.3 PRODUCT PORTFOLIO

14.4.4 RECENT DEVELOPMENTS

14.5 SCHILLER AG

14.5.1 COMPANY SNAPSHOT

14.5.2 COMPANY SHARE ANALYSIS

14.5.3 PRODUCT PORTFOLIO

14.5.4 RECENT DEVELOPMENTS

14.6 CHEST M.I., INC.

14.6.1 COMPANY SNAPSHOT

14.6.2 PRODUCT PORTFOLIO

14.6.3 RECENT DEVELOPMENTS

14.7 CLARITY MEDICAL

14.7.1 COMPANY SNAPSHOT

14.7.2 PRODUCT PORTFOLIO

14.7.3 RECENT DEVELOPMENT

14.8 CONTEC MEDICAL SYSTEMS CO., LTD

14.8.1 COMPANY SNAPSHOT

14.8.2 PRODUCT PORTFOLIO

14.8.3 RECENT DEVELOPMENT

14.9 DATA SCIENCES INTERNATIONAL.

14.9.1 COMPANY SNAPSHOT

14.9.2 PRODUCT PORTFOLIO

14.9.3 RECENT DEVELOPMENTS

14.1 ECO MEDICS

14.10.1 COMPANY SNAPSHOT

14.10.2 PRODUCT PORTFOLIO

14.10.3 RECENT DEVELOPMENTS

14.11 FUKUDA SANGYO CO., LTD.

14.11.1 COMPANY SNAPSHOT

14.11.2 PRODUCT PORTFOLIO

14.11.3 RECENT DEVELOPMENT

14.12 GANSHORN MEDIZIN ELECTRONIC GMBH

14.12.1 COMPANY SNAPSHOT

14.12.2 PRODUCT PORTFOLIO

14.12.3 RECENT DEVELOPMENTS

14.13 GERATHERM MEDICAL AG

14.13.1 COMPANY SNAPSHOT

14.13.2 REVENUE ANALYSIS

14.13.3 PRODUCT PORTFOLIO

14.13.4 RECENT DEVELOPMENT

14.14 INGMAR MEDICAL

14.14.1 COMPANY SNAPSHOT

14.14.2 PRODUCT PORTFOLIO

14.14.3 RECENT DEVELOPMENT

14.15 INOFAB HEALTH (A CLARIO COMPANY)

14.15.1 COMPANY SNAPSHOT

14.15.2 PRODUCT PORTFOLIO

14.15.3 RECENT DEVELOPMENT

14.16 JK MEDICAL SYSTEMS PVT LTD.

14.16.1 COMPANY SNAPSHOT

14.16.2 PRODUCT PORTFOLIO

14.16.3 RECENT DEVELOPMENTS

14.17 KOKO, PFT

14.17.1 COMPANY SNAPSHOT

14.17.2 PRODUCT PORTFOLIO

14.17.3 RECENT DEVELOPMENTS

14.18 MEC

14.18.1 COMPANY SNAPSHOT

14.18.2 PRODUCT PORTFOLIO

14.18.3 RECENT DEVELOPMENT

14.19 MEDICAL EQUIPMENT EUROPE GMBH

14.19.1 COMPANY SNAPSHOT

14.19.2 PRODUCT PORTFOLIO

14.19.3 RECENT DEVELOPMENTS

14.2 MEDLINE

14.20.1 COMPANY SNAPSHOT

14.20.2 PRODUCT PORTFOLIO

14.20.3 RECENT DEVELOPMENT

14.21 MORGAN SCIENTIFIC

14.21.1 COMPANY SNAPSHOT

14.21.2 PRODUCT PORTFOLIO

14.21.3 RECENT DEVELOPMENTS

14.22 NDD MEDICAL TECHNOLOGIES

14.22.1 COMPANY SNAPSHOT

14.22.2 PRODUCT PORTFOLIO

14.22.3 RECENT DEVELOPMENTS

14.23 PULMONE ADVANCED MEDICAL DEVICES

14.23.1 COMPANY SNAPSHOT

14.23.2 PRODUCT PORTFOLIO

14.23.3 RECENT DEVELOPMENT

14.24 RECORDERS & MEDICARE SYSTEMS PRIVATE LIMITED

14.24.1 COMPANY SNAPSHOT

14.24.2 PRODUCT PORTFOLIO

14.24.3 RECENT DEVELOPMENT

14.25 SCIREQ

14.25.1 COMPANY SNAPSHOT

14.25.2 PRODUCT PORTFOLIO

14.25.3 RECENT DEVELOPMENT

14.26 SIBEL, S.A.U

14.26.1 COMPANY SNAPSHOT

14.26.2 PRODUCT PORTFOLIO

14.26.3 RECENT DEVELOPMENT

14.27 VITALOGRAPH

14.27.1 COMPANY SNAPSHOT

14.27.2 PRODUCT PORTFOLIO

14.27.3 RECENT DEVELOPMENT

15 QUESTIONNAIRE

16 RELATED REPORTS

Lista de Tablas

TABLE 1 GLOBAL DRUG DELIVERY DEVICES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 2 GLOBAL HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 3 GLOBAL HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 4 GLOBAL PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 5 GLOBAL PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (VOLUME IN UNIT)

TABLE 6 GLOBAL PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 7 GLOBAL PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 8 GLOBAL PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (VOLUME IN UNIT)

TABLE 9 GLOBAL MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 10 GLOBAL ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 11 GLOBAL NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 12 GLOBAL HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 13 GLOBAL HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 14 GLOBAL HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 15 GLOBAL SOFTWARE IN PULMONARY FUNCTION TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 16 GLOBAL SERVICES IN PULMONARY FUNCTION TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 17 GLOBAL PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 18 GLOBAL ADULT IN PULMONARY FUNCTION TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 19 GLOBAL ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 20 GLOBAL GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 21 GLOBAL GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 22 GLOBAL PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 23 GLOBAL PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 24 GLOBAL PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 25 GLOBAL OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 26 GLOBAL OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 27 GLOBAL RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 28 GLOBAL RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 29 GLOBAL PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 30 GLOBAL HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 31 GLOBAL HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 32 GLOBAL SPECIALTY CLINICS IN PULMONARY FUNCTION TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 33 GLOBAL DIAGNOSTICS LABORATORIES IN PULMONARY FUNCTION TESTING, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 34 GLOBAL HOME CARE SETTINGS IN PULMONARY FUNCTION TESTING, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 35 GLOBAL OTHERS IN PULMONARY FUNCTION TESTING, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 36 GLOBAL PULMONARY FUNCTION TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 37 NORTH AMERICA PULMONARY FUNCTION TESTING MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND)

TABLE 38 NORTH AMERICA PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 39 NORTH AMERICA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 40 NORTH AMERICA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 41 NORTH AMERICA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 42 NORTH AMERICA PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 43 NORTH AMERICA MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 44 NORTH AMERICA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 45 NORTH AMERICA NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 46 NORTH AMERICA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 47 NORTH AMERICA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 48 NORTH AMERICA RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 49 NORTH AMERICA PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 50 NORTH AMERICA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 51 NORTH AMERICA GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 52 NORTH AMERICA PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 53 NORTH AMERICA PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 54 NORTH AMERICA OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 55 NORTH AMERICA RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 56 NORTH AMERICA PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 57 NORTH AMERICA HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 58 U.S. PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 59 U.S. HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 60 U.S. PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 61 U.S. PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 62 U.S. PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 63 U.S. MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 64 U.S. ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 65 U.S. NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 66 U.S. HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 67 U.S. HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 68 U.S. RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 69 U.S. PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 70 U.S. ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 71 U.S. GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 72 U.S. PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 73 U.S. PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 74 U.S. OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 75 U.S. RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 76 U.S. PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 77 U.S. HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 78 CANADA PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 79 CANADA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 80 CANADA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 81 CANADA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 82 CANADA PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 83 CANADA MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 84 CANADA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 85 CANADA NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 86 CANADA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 87 CANADA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 88 CANADA RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 89 CANADA PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 90 CANADA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 91 CANADA GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 92 CANADA PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 93 CANADA PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 94 CANADA OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 95 CANADA RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 96 CANADA PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 97 CANADA HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 98 MEXICO PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 99 MEXICO HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 100 MEXICO PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 101 MEXICO PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 102 MEXICO PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 103 MEXICO MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 104 MEXICO ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 105 MEXICO NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 106 MEXICO HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 107 MEXICO HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 108 MEXICO RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 109 MEXICO PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 110 MEXICO ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 111 MEXICO GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 112 MEXICO PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 113 MEXICO PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 114 MEXICO OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 115 MEXICO RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 116 MEXICO PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 117 MEXICO HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 118 EUROPE PULMONARY FUNCTION TESTING MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND)

TABLE 119 EUROPE PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 120 EUROPE HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 121 EUROPE PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 122 EUROPE PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 123 EUROPE PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 124 EUROPE MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 125 EUROPE ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 126 EUROPE NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 127 EUROPE HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 128 EUROPE HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 129 EUROPE RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 130 EUROPE PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 131 EUROPE ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 132 EUROPE GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 133 EUROPE PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 134 EUROPE PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 135 EUROPE OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 136 EUROPE RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 137 EUROPE PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 138 EUROPE HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 139 GERMANY PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 140 GERMANY HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 141 GERMANY PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 142 GERMANY PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 143 GERMANY PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 144 GERMANY MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 145 GERMANY ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 146 GERMANY NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 147 GERMANY HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 148 GERMANY HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 149 GERMANY RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 150 GERMANY PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 151 GERMANY ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 152 GERMANY GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 153 GERMANY PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 154 GERMANY PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 155 GERMANY OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 156 GERMANY RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 157 GERMANY PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 158 GERMANY HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 159 U.K. PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 160 U.K. HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 161 U.K. PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 162 U.K. PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 163 U.K. PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 164 U.K. MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 165 U.K. ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 166 U.K. NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 167 U.K. HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 168 U.K. HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 169 U.K. RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 170 U.K. PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 171 U.K. ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 172 U.K. GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 173 U.K. PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 174 U.K. PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 175 U.K. OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 176 U.K. RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 177 U.K. PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 178 U.K. HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 179 FRANCE PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 180 FRANCE HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 181 FRANCE PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 182 FRANCE PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 183 FRANCE PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 184 FRANCE MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 185 FRANCE ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 186 FRANCE NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 187 FRANCE HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 188 FRANCE HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 189 FRANCE RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 190 FRANCE PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 191 FRANCE ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 192 FRANCE GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 193 FRANCE PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 194 FRANCE PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 195 FRANCE OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 196 FRANCE RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 197 FRANCE PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 198 FRANCE HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 199 SPAIN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 200 SPAIN HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 201 SPAIN PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 202 SPAIN PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 203 SPAIN PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 204 SPAIN MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 205 SPAIN ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 206 SPAIN NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 207 SPAIN HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 208 SPAIN HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 209 SPAIN RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 210 SPAIN PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 211 SPAIN ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 212 SPAIN GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 213 SPAIN PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 214 SPAIN PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 215 SPAIN OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 216 SPAIN RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 217 SPAIN PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 218 SPAIN HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 219 ITALY PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 220 ITALY HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 221 ITALY PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 222 ITALY PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 223 ITALY PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 224 ITALY MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 225 ITALY ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 226 ITALY NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 227 ITALY HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 228 ITALY HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 229 ITALY RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 230 ITALY PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 231 ITALY ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 232 ITALY GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 233 ITALY PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 234 ITALY PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 235 ITALY OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 236 ITALY RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 237 ITALY PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 238 ITALY HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 239 TURKEY PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 240 TURKEY HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 241 TURKEY PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 242 TURKEY PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 243 TURKEY PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 244 TURKEY MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 245 TURKEY ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 246 TURKEY NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 247 TURKEY HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 248 TURKEY HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 249 TURKEY RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 250 TURKEY PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 251 TURKEY ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 252 TURKEY GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 253 TURKEY PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 254 TURKEY PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 255 TURKEY OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 256 TURKEY RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 257 TURKEY PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 258 TURKEY HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 259 RUSSIA PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 260 RUSSIA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 261 RUSSIA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 262 RUSSIA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 263 RUSSIA PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 264 RUSSIA MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 265 RUSSIA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 266 RUSSIA NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 267 RUSSIA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 268 RUSSIA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 269 RUSSIA RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 270 RUSSIA PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 271 RUSSIA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 272 RUSSIA GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 273 RUSSIA PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 274 RUSSIA PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 275 RUSSIA OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 276 RUSSIA RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 277 RUSSIA PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 278 RUSSIA HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 279 SWITZERLAND PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 280 SWITZERLAND HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 281 SWITZERLAND PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 282 SWITZERLAND PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 283 SWITZERLAND PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 284 SWITZERLAND MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 285 SWITZERLAND ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 286 SWITZERLAND NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 287 SWITZERLAND HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 288 SWITZERLAND HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 289 SWITZERLAND RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 290 SWITZERLAND PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 291 SWITZERLAND ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 292 SWITZERLAND GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 293 SWITZERLAND PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 294 SWITZERLAND PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 295 SWITZERLAND OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 296 SWITZERLAND RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 297 SWITZERLAND PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 298 SWITZERLAND HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 299 NETHERLANDS PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 300 NETHERLANDS HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 301 NETHERLANDS PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 302 NETHERLANDS PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 303 NETHERLANDS PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 304 NETHERLANDS MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 305 NETHERLANDS ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 306 NETHERLANDS NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 307 NETHERLANDS HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 308 NETHERLANDS HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 309 NETHERLANDS RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 310 NETHERLANDS PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 311 NETHERLANDS ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 312 NETHERLANDS GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 313 NETHERLANDS PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 314 NETHERLANDS PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 315 NETHERLANDS OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 316 NETHERLANDS RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 317 NETHERLANDS PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 318 NETHERLANDS HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 319 SWEDEN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 320 SWEDEN HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 321 SWEDEN PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 322 SWEDEN PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 323 SWEDEN PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 324 SWEDEN MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 325 SWEDEN ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 326 SWEDEN NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 327 SWEDEN HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 328 SWEDEN HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 329 SWEDEN RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 330 SWEDEN PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 331 SWEDEN ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 332 SWEDEN GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 333 SWEDEN PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 334 SWEDEN PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 335 SWEDEN OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 336 SWEDEN RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 337 SWEDEN PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 338 SWEDEN HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 339 BELGIUM PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 340 BELGIUM HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 341 BELGIUM PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 342 BELGIUM PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 343 BELGIUM PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 344 BELGIUM MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 345 BELGIUM ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 346 BELGIUM NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 347 BELGIUM HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 348 BELGIUM HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 349 BELGIUM RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 350 BELGIUM PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 351 BELGIUM ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 352 BELGIUM GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 353 BELGIUM PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 354 BELGIUM PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 355 BELGIUM OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 356 BELGIUM RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 357 BELGIUM PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 358 BELGIUM HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 359 DENMARK PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 360 DENMARK HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 361 DENMARK PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 362 DENMARK PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 363 DENMARK PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 364 DENMARK MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 365 DENMARK ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 366 DENMARK NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 367 DENMARK HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 368 DENMARK HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 369 DENMARK RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 370 DENMARK PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 371 DENMARK ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 372 DENMARK GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 373 DENMARK PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 374 DENMARK PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 375 DENMARK OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 376 DENMARK RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 377 DENMARK PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 378 DENMARK HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 379 NORWAY PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 380 NORWAY HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 381 NORWAY PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 382 NORWAY PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 383 NORWAY PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 384 NORWAY MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 385 NORWAY ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 386 NORWAY NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 387 NORWAY HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 388 NORWAY HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 389 NORWAY RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 390 NORWAY PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 391 NORWAY ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 392 NORWAY GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 393 NORWAY PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 394 NORWAY PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 395 NORWAY OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 396 NORWAY RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 397 NORWAY PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 398 NORWAY HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 399 FINLAND PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 400 FINLAND HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 401 FINLAND PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 402 FINLAND PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 403 FINLAND PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 404 FINLAND MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 405 FINLAND ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 406 FINLAND NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 407 FINLAND HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 408 FINLAND HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 409 FINLAND RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 410 FINLAND PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 411 FINLAND ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 412 FINLAND GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 413 FINLAND PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 414 FINLAND PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 415 FINLAND OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 416 FINLAND RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 417 FINLAND PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 418 FINLAND HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 419 POLAND PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 420 POLAND HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 421 POLAND PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 422 POLAND PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 423 POLAND PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 424 POLAND MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 425 POLAND ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 426 POLAND NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 427 POLAND HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 428 POLAND HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 429 POLAND RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 430 POLAND PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 431 POLAND ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 432 POLAND GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 433 POLAND PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 434 POLAND PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 435 POLAND OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 436 POLAND RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 437 POLAND PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 438 POLAND HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 439 REST OF EUROPE PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 440 ASIA-PACIFIC PULMONARY FUNCTION TESTING MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND)

TABLE 441 ASIA-PACIFIC PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 442 ASIA-PACIFIC HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 443 ASIA-PACIFIC PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 444 ASIA-PACIFIC PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 445 ASIA-PACIFIC PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 446 ASIA-PACIFIC MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 447 ASIA-PACIFIC ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 448 ASIA-PACIFIC NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 449 ASIA-PACIFIC HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 450 ASIA-PACIFIC HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 451 ASIA-PACIFIC RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 452 ASIA-PACIFIC PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 453 ASIA-PACIFIC ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 454 ASIA-PACIFIC GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 455 ASIA-PACIFIC PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 456 ASIA-PACIFIC PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 457 ASIA-PACIFIC OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 458 ASIA-PACIFIC RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 459 ASIA-PACIFIC PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 460 ASIA-PACIFIC HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 461 JAPAN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 462 JAPAN HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 463 JAPAN PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 464 JAPAN PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 465 JAPAN PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 466 JAPAN MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 467 JAPAN ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 468 JAPAN NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 469 JAPAN HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 470 JAPAN HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 471 JAPAN RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 472 JAPAN PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 473 JAPAN ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 474 JAPAN GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 475 JAPAN PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 476 JAPAN PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 477 JAPAN OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 478 JAPAN RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 479 JAPAN PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 480 JAPAN HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 481 CHINA PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 482 CHINA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 483 CHINA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 484 CHINA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 485 CHINA PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 486 CHINA MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 487 CHINA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 488 CHINA NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 489 CHINA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 490 CHINA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 491 CHINA RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 492 CHINA PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 493 CHINA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 494 CHINA GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 495 CHINA PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 496 CHINA PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 497 CHINA OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 498 CHINA RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 499 CHINA PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 500 CHINA HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 501 SOUTH KOREA PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 502 SOUTH KOREA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 503 SOUTH KOREA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 504 SOUTH KOREA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 505 SOUTH KOREA PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 506 SOUTH KOREA MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 507 SOUTH KOREA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 508 SOUTH KOREA NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 509 SOUTH KOREA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 510 SOUTH KOREA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 511 SOUTH KOREA RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 512 SOUTH KOREA PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 513 SOUTH KOREA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 514 SOUTH KOREA GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 515 SOUTH KOREA PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 516 SOUTH KOREA PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 517 SOUTH KOREA OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 518 SOUTH KOREA RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 519 SOUTH KOREA PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 520 SOUTH KOREA HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 521 INDIA PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 522 INDIA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 523 INDIA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 524 INDIA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 525 INDIA PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 526 INDIA MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 527 INDIA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 528 INDIA NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 529 INDIA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 530 INDIA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 531 INDIA RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 532 INDIA PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 533 INDIA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 534 INDIA GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 535 INDIA PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 536 INDIA PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 537 INDIA OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 538 INDIA RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 539 INDIA PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 540 INDIA HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 541 AUSTRALIA PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 542 AUSTRALIA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 543 AUSTRALIA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 544 AUSTRALIA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 545 AUSTRALIA PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 546 AUSTRALIA MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 547 AUSTRALIA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 548 AUSTRALIA NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 549 AUSTRALIA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 550 AUSTRALIA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 551 AUSTRALIA RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 552 AUSTRALIA PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 553 AUSTRALIA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 554 USTRALIA GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 555 AUSTRALIA PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 556 AUSTRALIA PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 557 AUSTRALIA OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 558 AUSTRALIA RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 559 AUSTRALIA PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 560 AUSTRALIA HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 561 SINGAPORE PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 562 SINGAPORE HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 563 SINGAPORE PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 564 SINGAPORE PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 565 SINGAPORE PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 566 SINGAPORE MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 567 SINGAPORE ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 568 SINGAPORE NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 569 SINGAPORE HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 570 SINGAPORE HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 571 SINGAPORE RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 572 SINGAPORE PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 573 SINGAPORE ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 574 SINGAPORE GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 575 SINGAPORE PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 576 SINGAPORE PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 577 SINGAPORE OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 578 SINGAPORE RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 579 SINGAPORE PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 580 SINGAPORE HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 581 TAIWAN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 582 TAIWAN HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 583 TAIWAN PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 584 TAIWAN PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 585 TAIWAN PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 586 TAIWAN MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 587 TAIWAN ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 588 TAIWAN NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 589 TAIWAN HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 590 TAIWAN HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 591 TAIWAN RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 592 TAIWAN PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 593 TAIWAN ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 594 TAIWAN GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 595 TAIWAN PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 596 TAIWAN PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 597 TAIWAN OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 598 TAIWAN RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 599 TAIWAN PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 600 TAIWAN HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 601 THAILAND PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 602 THAILAND HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 603 THAILAND PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 604 THAILAND PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 605 THAILAND PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 606 THAILAND MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 607 THAILAND ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 608 THAILAND NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 609 THAILAND HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 610 THAILAND HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 611 THAILAND RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 612 THAILAND PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 613 THAILAND ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 614 THAILAND GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 615 THAILAND PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 616 THAILAND PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 617 THAILAND OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 618 THAILAND RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 619 THAILAND PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 620 THAILAND HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 621 MALAYSIA PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 622 MALAYSIA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 623 MALAYSIA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 624 MALAYSIA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 625 MALAYSIA PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 626 MALAYSIA MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 627 MALAYSIA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 628 MALAYSIA NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 629 MALAYSIA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 630 MALAYSIA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 631 MALAYSIA RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 632 MALAYSIA PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 633 MALAYSIA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 634 MALAYSIA GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 635 MALAYSIA PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 636 MALAYSIA PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 637 MALAYSIA OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 638 MALAYSIA RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 639 MALAYSIA PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 640 MALAYSIA HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 641 NEW ZEALAND PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 642 NEW ZEALAND HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 643 NEW ZEALAND PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 644 NEW ZEALAND PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 645 NEW ZEALAND PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 646 NEW ZEALAND MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 647 NEW ZEALAND ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 648 NEW ZEALAND NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 649 NEW ZEALAND HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 650 NEW ZEALAND HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 651 NEW ZEALAND RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 652 NEW ZEALAND PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 653 NEW ZEALAND ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 654 NEW ZEALAND GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 655 NEW ZEALAND PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 656 NEW ZEALAND PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 657 NEW ZEALAND OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 658 NEW ZEALAND RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 659 NEW ZEALAND PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 660 NEW ZEALAND HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 661 INDONESIA PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 662 INDONESIA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 663 INDONESIA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 664 INDONESIA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 665 INDONESIA PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 666 INDONESIA MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 667 INDONESIA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 668 INDONESIA NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 669 INDONESIA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 670 INDONESIA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 671 INDONESIA RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 672 INDONESIA PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 673 INDONESIA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 674 INDONESIA GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 675 INDONESIA PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 676 INDONESIA PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 677 INDONESIA OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 678 INDONESIA RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 679 INDONESIA PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 680 INDONESIA HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 681 VIETNAM PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 682 VIETNAM HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 683 VIETNAM PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 684 VIETNAM PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 685 VIETNAM PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 686 VIETNAM MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 687 VIETNAM ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 688 VIETNAM NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 689 VIETNAM HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 690 VIETNAM HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 691 VIETNAM RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 692 VIETNAM PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 693 VIETNAM ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 694 VIETNAM GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 695 VIETNAM PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 696 VIETNAM PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 697 VIETNAM OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 698 VIETNAM RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 699 VIETNAM PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 700 VIETNAM HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 701 PHILIPPINES PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 702 PHILIPPINES HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 703 PHILIPPINES PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 704 PHILIPPINES PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 705 PHILIPPINES PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 706 PHILIPPINES MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 707 PHILIPPINES ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 708 PHILIPPINES NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 709 PHILIPPINES HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 710 PHILIPPINES HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 711 PHILIPPINES RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 712 PHILIPPINES PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 713 PHILIPPINES ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 714 PHILIPPINES GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 715 PHILIPPINES PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 716 PHILIPPINES PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 717 PHILIPPINES OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 718 PHILIPPINES RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 719 PHILIPPINES PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 720 PHILIPPINES HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 721 REST OF ASIA-PACIFIC PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 722 MIDDLE EAST AND AFRICA PULMONARY FUNCTION TESTING MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND)

TABLE 723 MIDDLE EAST AND AFRICA PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 724 MIDDLE EAST AND AFRICA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 725 MIDDLE EAST AND AFRICA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 726 MIDDLE EAST AND AFRICA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 727 MIDDLE EAST AND AFRICA PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 728 MIDDLE EAST AND AFRICA MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 729 MIDDLE EAST AND AFRICA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 730 MIDDLE EAST AND AFRICA NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 731 MIDDLE EAST AND AFRICA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 732 MIDDLE EAST AND AFRICA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 733 MIDDLE EAST AND AFRICA RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 734 MIDDLE EAST AND AFRICA PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 735 MIDDLE EAST AND AFRICA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 736 MIDDLE EAST AND AFRICA GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 737 MIDDLE EAST AND AFRICA PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 738 MIDDLE EAST AND AFRICA PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 739 MIDDLE EAST AND AFRICA OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 740 MIDDLE EAST AND AFRICA RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 741 MIDDLE EAST AND AFRICA PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 742 MIDDLE EAST AND AFRICA HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 743 SOUTH AFRICA PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 744 SOUTH AFRICA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 745 SOUTH AFRICA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 746 SOUTH AFRICA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 747 SOUTH AFRICA PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 748 SOUTH AFRICA MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 749 SOUTH AFRICA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 750 SOUTH AFRICA NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 751 SOUTH AFRICA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 752 SOUTH AFRICA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 753 SOUTH AFRICA RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 754 SOUTH AFRICA PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 755 SOUTH AFRICA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 756 SOUTH AFRICA GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 757 SOUTH AFRICA PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 758 SOUTH AFRICA PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 759 SOUTH AFRICA OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 760 SOUTH AFRICA RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 761 SOUTH AFRICA PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 762 SOUTH AFRICA HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 763 SAUDI ARABIA PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 764 SAUDI ARABIA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 765 SAUDI ARABIA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 766 SAUDI ARABIA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 767 SAUDI ARABIA PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 768 SAUDI ARABIA MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 769 SAUDI ARABIA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 770 SAUDI ARABIA NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 771 SAUDI ARABIA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 772 SAUDI ARABIA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 773 SAUDI ARABIA RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 774 SAUDI ARABIA PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 775 SAUDI ARABIA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 776 SAUDI ARABIA GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 777 SAUDI ARABIA PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 778 SAUDI ARABIA PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 779 SAUDI ARABIA OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 780 SAUDI ARABIA RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 781 SAUDI ARABIA PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 782 SAUDI ARABIA HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 783 U.A.E. PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 784 U.A.E. HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 785 U.A.E. PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 786 U.A.E. PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 787 U.A.E. PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 788 U.A.E. MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 789 U.A.E. ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 790 U.A.E. NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 791 U.A.E. HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 792 U.A.E. HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 793 U.A.E. RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 794 U.A.E. PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 795 U.A.E. ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 796 U.A.E. GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 797 U.A.E. PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 798 U.A.E. PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 799 U.A.E. OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 800 U.A.E. RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 801 U.A.E. PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 802 U.A.E. HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 803 ISRAEL PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 804 ISRAEL HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 805 ISRAEL PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 806 ISRAEL PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 807 ISRAEL PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 808 ISRAEL MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 809 ISRAEL ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 810 ISRAEL NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 811 ISRAEL HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 812 ISRAEL HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 813 ISRAEL RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 814 ISRAEL PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 815 ISRAEL ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 816 ISRAEL GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 817 ISRAEL PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 818 ISRAEL PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 819 ISRAEL OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 820 ISRAEL RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 821 ISRAEL PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 822 ISRAEL HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 823 QATAR PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 824 QATAR HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 825 QATAR PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 826 QATAR PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 827 QATAR PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 828 QATAR MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 829 QATAR ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 830 QATAR NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 831 QATAR HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 832 QATAR HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 833 QATAR RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 834 QATAR PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 835 QATAR ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 836 QATAR GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 837 QATAR PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 838 QATAR PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 839 QATAR OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 840 QATAR RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 841 QATAR PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 842 QATAR HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 843 KUWAIT PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 844 KUWAIT HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 845 KUWAIT PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 846 KUWAIT PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 847 KUWAIT PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 848 KUWAIT MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 849 KUWAIT ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 850 KUWAIT NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 851 KUWAIT HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 852 KUWAIT HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 853 KUWAIT RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 854 KUWAIT PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 855 KUWAIT ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 856 KUWAIT GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 857 KUWAIT PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 858 KUWAIT PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 859 KUWAIT OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 860 KUWAIT RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 861 KUWAIT PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 862 KUWAIT HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 863 EGYPT PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 864 EGYPT HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 865 EGYPT PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 866 EGYPT PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 867 EGYPT PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 868 EGYPT MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 869 EGYPT ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 870 EGYPT NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 871 EGYPT HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 872 EGYPT HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 873 EGYPT RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 874 EGYPT PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 875 EGYPT ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 876 EGYPT GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 877 EGYPT PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 878 EGYPT PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 879 EGYPT OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 880 EGYPT RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 881 EGYPT PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 882 EGYPT HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 883 OMAN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 884 OMAN HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 885 OMAN PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 886 OMAN PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 887 OMAN PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 888 OMAN MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 889 OMAN ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 890 OMAN NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 891 OMAN HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 892 OMAN HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 893 OMAN RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 894 OMAN PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 895 OMAN ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 896 OMAN GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 897 OMAN PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 898 OMAN PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 899 OMAN OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 900 OMAN RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 901 OMAN PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 902 OMAN HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 903 BAHRAIN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 904 BAHRAIN HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 905 BAHRAIN PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 906 BAHRAIN PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 907 BAHRAIN MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 908 BAHRAIN ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 909 BAHRAIN NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 910 BAHRAIN HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 911 BAHRAIN HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 912 BAHRAIN RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 913 BAHRAIN PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 914 BAHRAIN ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 915 BAHRAIN GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 916 BAHRAIN PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 917 BAHRAIN PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 918 BAHRAIN OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 919 BAHRAIN RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 920 BAHRAIN PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 921 BAHRAIN HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 922 REST OF MIDDLE EAST AND AFRICA PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 923 SOUTH AMERICA PULMONARY FUNCTION TESTING MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND)

TABLE 924 SOUTH AMERICA PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 925 SOUTH AMERICA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 926 SOUTH AMERICA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 927 SOUTH AMERICA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 928 SOUTH AMERICA PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 929 SOUTH AMERICA MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 930 SOUTH AMERICA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 931 SOUTH AMERICA NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 932 SOUTH AMERICA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 933 SOUTH AMERICA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 934 SOUTH AMERICA RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 935 SOUTH AMERICA PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 936 SOUTH AMERICA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 937 SOUTH AMERICA GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 938 SOUTH AMERICA PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 939 SOUTH AMERICA PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 940 SOUTH AMERICA OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 941 SOUTH AMERICA RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 942 SOUTH AMERICA PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 943 SOUTH AMERICA HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 944 BRAZIL PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 945 BRAZIL HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 946 BRAZIL PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 947 BRAZIL PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 948 BRAZIL PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 949 BRAZIL MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 950 BRAZIL ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 951 BRAZIL NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 952 BRAZIL HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 953 BRAZIL HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 954 BRAZIL RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 955 BRAZIL PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 956 BRAZIL ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 957 BRAZIL GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 958 BRAZIL PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 959 BRAZIL PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 960 BRAZIL OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 961 BRAZIL RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 962 BRAZIL PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 963 BRAZIL HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 964 ARGENTINA PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 965 ARGENTINA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 966 ARGENTINA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 967 ARGENTINA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 968 ARGENTINA PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 969 ARGENTINA MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 970 ARGENTINA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 971 ARGENTINA NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 972 ARGENTINA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 973 ARGENTINA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 974 ARGENTINA RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 975 ARGENTINA PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 976 ARGENTINA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 977 ARGENTINA GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 978 ARGENTINA PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 979 ARGENTINA PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 980 ARGENTINA OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 981 ARGENTINA RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 982 ARGENTINA PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 983 ARGENTINA HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 984 REST OF SOUTH AMERICA PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

Lista de figuras

FIGURE 1 GLOBAL PULMONARY FUNCTION TESTING MARKET: SEGMENTATION

FIGURE 2 GLOBAL PULMONARY FUNCTION TESTING MARKET: DATA TRIANGULATION

FIGURE 3 GLOBAL PULMONARY FUNCTION TESTING MARKET: DROC ANALYSIS

FIGURE 4 GLOBAL PULMONARY FUNCTION TESTING MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS

FIGURE 5 GLOBAL PULMONARY FUNCTION TESTING MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 GLOBAL PULMONARY FUNCTION TESTING MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 GLOBAL PULMONARY FUNCTION TESTING MARKET: MARKET APPLICATION COVERAGE GRID

FIGURE 8 GLOBAL PULMONARY FUNCTION TESTING MARKET: DBMR MARKET POSITION GRID

FIGURE 9 GLOBAL PULMONARY FUNCTION TESTING MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 GLOBAL PULMONARY FUNCTION TESTING MARKET: SEGMENTATION

FIGURE 11 GLOBAL PULMONARY FUNCTION TESTING MARKET, BY TYPE

FIGURE 12 EXECUTIVE SUMMARY

FIGURE 13 STRATEGIC DECISIONS

FIGURE 14 INCREASING PREVALENCE OF RESPIRATORY DISEASES IS DRIVING THE GROWTH OF THE GLOBAL PULMONARY FUNCTION TESTING MARKET FROM 2024 TO 2031

FIGURE 15 THE HARDWARE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL PULMONARY FUNCTION TESTING MARKET IN 2024 AND 2031

FIGURE 16 DROC ANALYSIS

FIGURE 17 GLOBAL PULMONARY FUNCTION TESTING MARKET: BY TYPE, 2023

FIGURE 18 GLOBAL PULMONARY FUNCTION TESTING MARKET: BY TYPE, 2024-2031 (USD THOUSAND)

FIGURE 19 GLOBAL PULMONARY FUNCTION TESTING MARKET: BY TYPE, CAGR (2024-2031)

FIGURE 20 GLOBAL PULMONARY FUNCTION TESTING MARKET: BY TYPE, LIFELINE CURVE

FIGURE 21 GLOBAL PULMONARY FUNCTION TESTING MARKET: BY PATIENT TYPE, 2023

FIGURE 22 GLOBAL PULMONARY FUNCTION TESTING MARKET: BY PATIENT TYPE, 2024-2031 (USD THOUSAND)

FIGURE 23 GLOBAL PULMONARY FUNCTION TESTING MARKET: BY PATIENT TYPE, CAGR (2024-2031)

FIGURE 24 GLOBAL PULMONARY FUNCTION TESTING MARKET: BY PATIENT TYPE, LIFELINE CURVE

FIGURE 25 GLOBAL PULMONARY FUNCTION TESTING MARKET: BY APPLICATION 2023

FIGURE 26 GLOBAL PULMONARY FUNCTION TESTING MARKET: BY APPLICATION, 2024-2031 (USD THOUSAND)

FIGURE 27 GLOBAL PULMONARY FUNCTION TESTING MARKET: BY APPLICATION, CAGR (2024-2031)

FIGURE 28 GLOBAL PULMONARY FUNCTION TESTING MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 29 GLOBAL PULMONARY FUNCTION TESTING MARKET: BY END USER 2023

FIGURE 30 GLOBAL PULMONARY FUNCTION TESTING MARKET: BY END USER, 2024-2031 (USD THOUSAND)

FIGURE 31 GLOBAL PULMONARY FUNCTION TESTING MARKET: END USER, CAGR (2024-2031)

FIGURE 32 GLOBAL PULMONARY FUNCTION TESTING MARKET: END USER, LIFELINE CURVE

FIGURE 33 GLOBAL PULMONARY FUNCTION TESTING MARKET: SNAPSHOT (2023)

FIGURE 34 GLOBAL PULMONARY FUNCTION TESTING MARKET: COMPANY SHARE 2023 (%)

FIGURE 35 NORTH AMERICA PULMONARY FUNCTION TESTING MARKET: COMPANY SHARE 2023 (%)

FIGURE 36 EUROPE MEDICAL IMAGE MANAGEMENT MARKET: COMPANY SHARE 2023 (%)

FIGURE 37 ASIA-PACIFIC PULMONARY FUNCTION TESTING MARKET: COMPANY SHARE 2023 (%)

Ver información detallada Right Arrow

Metodología de investigación

La recopilación de datos y el análisis del año base se realizan utilizando módulos de recopilación de datos con muestras de gran tamaño. La etapa incluye la obtención de información de mercado o datos relacionados a través de varias fuentes y estrategias. Incluye el examen y la planificación de todos los datos adquiridos del pasado con antelación. Asimismo, abarca el examen de las inconsistencias de información observadas en diferentes fuentes de información. Los datos de mercado se analizan y estiman utilizando modelos estadísticos y coherentes de mercado. Además, el análisis de la participación de mercado y el análisis de tendencias clave son los principales factores de éxito en el informe de mercado. Para obtener más información, solicite una llamada de un analista o envíe su consulta.

La metodología de investigación clave utilizada por el equipo de investigación de DBMR es la triangulación de datos, que implica la extracción de datos, el análisis del impacto de las variables de datos en el mercado y la validación primaria (experto en la industria). Los modelos de datos incluyen cuadrícula de posicionamiento de proveedores, análisis de línea de tiempo de mercado, descripción general y guía del mercado, cuadrícula de posicionamiento de la empresa, análisis de patentes, análisis de precios, análisis de participación de mercado de la empresa, estándares de medición, análisis global versus regional y de participación de proveedores. Para obtener más información sobre la metodología de investigación, envíe una consulta para hablar con nuestros expertos de la industria.

Personalización disponible

Data Bridge Market Research es líder en investigación formativa avanzada. Nos enorgullecemos de brindar servicios a nuestros clientes existentes y nuevos con datos y análisis que coinciden y se adaptan a sus objetivos. El informe se puede personalizar para incluir análisis de tendencias de precios de marcas objetivo, comprensión del mercado de países adicionales (solicite la lista de países), datos de resultados de ensayos clínicos, revisión de literatura, análisis de mercado renovado y base de productos. El análisis de mercado de competidores objetivo se puede analizar desde análisis basados ​​en tecnología hasta estrategias de cartera de mercado. Podemos agregar tantos competidores sobre los que necesite datos en el formato y estilo de datos que esté buscando. Nuestro equipo de analistas también puede proporcionarle datos en archivos de Excel sin procesar, tablas dinámicas (libro de datos) o puede ayudarlo a crear presentaciones a partir de los conjuntos de datos disponibles en el informe.

Preguntas frecuentes

El mercado se segmenta según Segmentación del mercado global de pruebas de función pulmonar por tipo (hardware, servicios y software), tipo de paciente (pediátrico, adulto y geriátrico), aplicación (enfermedad pulmonar obstructiva y restrictiva), usuario final (hospital, clínicas especializadas, laboratorios de diagnóstico, centros de atención domiciliaria, etc.): tendencias y pronóstico del sector hasta 2032. .
El tamaño del Informe de análisis del tamaño, la participación y las tendencias del mercado se valoró en 3.88 USD Billion USD en 2024.
Se prevé que el Informe de análisis del tamaño, la participación y las tendencias del mercado crezca a una CAGR de 6.1% durante el período de pronóstico de 2025 a 2032.
Los principales actores del mercado incluyen BD , SCHILLER CoSMED srl , NSPIRE Healthcare , MGC DIAGNOSTICS CORPORATION , ndd Medical Technologies , Morgan ScientificInc. , Ganshorn Medizin Electronic GmbH , Minato Holdings Inc. , CHEST M.I.Inc. , Koninklijke Philips N.V. , medical equipment europe GmbH , Omron HealthcareInc. , Medtronic .
Testimonial